After successfully raising £801,257, Weedingtech is positioned to replace the weed-killing market’s leading brand in response to laws tightening across a number of EU countries to limit the use of herbicides.

The Story

After studies by the World Health Organisation and the International Agency for Research on Cancer concluded that the world’s most widely used weedkiller ‘probably’ causes cancer, companies across Europe began to tighten legislation and ban the use of herbicides in public areas.

Weedingtech is Europe’s leading herbicide-free weed control company, using thermal technology rather than potentially dangerous herbicides for a solution that is safe, sustainable and scalable. Its leading product, Foamstream, heats a mixture of foam and hot water to 99 degrees which is then sprayed on the targeted weeds. This trade-secret foam then acts as a thermal blanket to contain the water’s heat and break down the waxy exterior walls of the weed to ensure an effective kill.

BXq BG0oi Lr R02Vjtv RsI

Where are they now?

Weedingtech technology is already used extensively by councils, service companies and organisations across the UK and Europe, including Yeo Valley, Quadron, South West Water, Svevia and SITA. It therefore comes as no surprise that Weedingtech had already achieved more than 75% of its 2015 sales target by June with over £250k of booked revenue.

Furthermore, Weedingtech’s ‘Foamstream’ has won praise and backing from a variety of bodies including the Soil Association and PAN UK (Pesticides Action Network UK), as well as a number of awards, including:

- ‘Most Innovative Product’ at LAMMA 2012

- ‘Guardian Edge Innovation award’ at Saltex 2012

- Rushlight Sustainability Initiative Award 2015

- Rushlight Responsible Product Award 2015

February 2018 update

Weedingtech have reported a 100% year-on-year revenue growth as non-chemical approaches gain popularity. The company also received a £3m investment from Calculus Capital.

See current opportunities

Electrospinning

EIS
Medtech
Electrospinning makes technology that can be used in 3D printing human tissue, such as an eye or joint. Find out about there funding round here.

Active

Trading status

£10,319

Average investment

£381,790

Total raised

SeeQuestor

EIS
Transport & Logistics
Improving CCTV analysis to help solve crimes more efficiently and effectively, SeeQuestor raised funding on SyndicateRoom.

Active

Trading status

£14,065

Average investment

£872,034

Total raised

Apta Biosciences Ltd

EIS
Pharmaceuticals & Biotechnology
Game-changing technology for multi-billion dollar life sciences research, diagnostics and therapeutics markets. Read about Apta Biosciences raise here.

Active

Trading status

£9,944

Average investment

£964,550

Total raised

The Diabetic Boot Company

EIS
Medtech
Developing a unique wound healing device, focussed on saving diabetics from lower limb amputations. The global market for this product exceeds $1 billion.

Active

Trading status

£21,784

Average investment

£1,764,494

Total raised

Fertility Focus - Round 2

EIS
Medtech
The only product on the market that detects ovulation with 99% accuracy, Fertility Focus raised funds on SyndicateRoom. Read about the raise here.

Active

Trading status

£10,917

Average investment

£360,250

Total raised

Bactest - Round 2

EIS
Pharmaceuticals & Biotechnology
Bactest develops and sells products based on its propriety technology platform that turns microbial activity into data.

No longer trading

Trading status

£12,070

Average investment

£301,760

Total raised